Marta Scandurra
Helsinn (Switzerland)(CH)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, Ubiquitin and proteasome pathways, NF-κB Signaling Pathways
Most-Cited Works
- → Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma(2009)1,031 cited
- → Effect of titanium carbide coating on the osseointegration response in vitro and in vivo(2006)139 cited
- → BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome(2009)109 cited
- → Genome wide DNA‐profiling of HIV‐related B‐cell lymphomas(2009)76 cited
- → Genome‐wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion(2008)70 cited
- → Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma(2013)68 cited
- → Single nucleotide polymorphism‐arrays provide new insights in the pathogenesis of post‐transplant diffuse large B‐cell lymphoma(2010)55 cited
- → Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B‐cell lymphomas(2009)54 cited
- → Genomic lesions associated with a different clinical outcome in diffuse large B‐Cell lymphoma treated with R‐CHOP‐21(2010)52 cited
- → Diffuse large B‐cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome(2010)39 cited